Samira Farboodmanesh

Samira Farboodmanesh, Ph.D., is a seasoned regulatory affairs professional with extensive experience in leading global regulatory strategies within the biopharmaceutical industry. Currently serving as Executive Director of Regulatory Affairs at MannKind Corporation, Samira has held senior regulatory roles at Hemab Therapeutics and Lyra Therapeutics, where strategic guidance and support for clinical and non-clinical activities were key responsibilities. Previously, at Takeda, Samira directed global regulatory efforts for complex projects in rare disease and managed multidisciplinary teams in the development of orphan drug products. Early career experiences include significant contributions at AstraZeneca, MilliporeSigma, and academic positions at the University of Massachusetts Lowell, where a strong foundation in mechanical engineering and tissue engineering research was established. Samira holds a Ph.D. in Mechanical Engineering from the University of Massachusetts Lowell and is recognized for mentoring students and leading innovative research initiatives.